NEW YORK (GenomeWeb) – Fluidigm said Thursday morning that its first quarter revenues increased 9 percent year over year.

For the three months ended March 31, the South San Francisco, California-based firm brought in $29 million, compared to $26.7 million in the first quarter of 2015. Total revenues beat the consensus Wall Street estimate of $27.0 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.